Literature DB >> 25464837

Is the Eating Disorder Questionnaire-Online (EDQ-O) a valid diagnostic instrument for the DSM-IV-TR classification of eating disorders?

Elke D ter Huurne1, Hein A de Haan2, Marieke C ten Napel-Schutz3, Marloes G Postel4, Juliane Menting5, Job van der Palen6, Maartje S Vroling7, Cor A J DeJong8.   

Abstract

BACKGROUND: The Eating Disorder Questionnaire-Online (EDQ-O) is an online self-report questionnaire, which was developed specifically to provide a DSM-IV-TR classification of anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), and eating disorder not otherwise specified (EDNOS), without using a face-to-face clinical interview.
OBJECTIVE: The purpose of the present study was to examine the psychometric quality of the EDQ-O.
METHODS: The validity of the EDQ-O was determined by examining the agreement with the diagnoses obtained from the Longitudinal, Expert, and All DATA (LEAD) standard. Participants included 134 new patients of a specialist center for eating disorders located in the Netherlands.
RESULTS: Assessment of the validity of the EDQ-O yielded acceptable to good AUC (area under the receiver operating characteristic curve) values with a range from 0.72 to 0.83. Most other diagnostic efficiency statistics were also good except for a low sensitivity for AN (0.44), a low positive predictive value for BN (0.50), and a relatively low sensitivity for BED (0.66).
CONCLUSION: The results of the present study suggest that the EDQ-O performs acceptably as a diagnostic instrument for all DSM-IV-TR eating disorder classifications. However, suggestions are made to further improve the validity of the EDQ-O.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25464837     DOI: 10.1016/j.comppsych.2014.10.019

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  7 in total

Review 1.  Recognizing Binge-Eating Disorder in the Clinical Setting: A Review of the Literature.

Authors:  Susan G Kornstein; Jelena L Kunovac; Barry K Herman; Larry Culpepper
Journal:  Prim Care Companion CNS Disord       Date:  2016-05-26

2.  Long-term effectiveness of web-based cognitive behavioral therapy for patients with eating disorders.

Authors:  Elke D Ter Huurne; Hein A de Haan; Marloes G Postel; Cor A J DeJong; Joanne E L VanDerNagel; Job van der Palen
Journal:  Eat Weight Disord       Date:  2020-05-24       Impact factor: 4.652

Review 3.  E-Health Interventions for Eating Disorders: Emerging Findings, Issues, and Opportunities.

Authors:  Jiska J Aardoom; Alexandra E Dingemans; Eric F Van Furth
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

Review 4.  New Horizons in Measurement: a Review of Novel and Innovative Approaches to Eating-Disorder Assessment.

Authors:  Kelsie T Forbush; Sara R Gould; Danielle A N Chapa; Brittany K Bohrer; Kelsey E Hagan; Kelsey E Clark; Daria A Sorokina; Victoria L Perko
Journal:  Curr Psychiatry Rep       Date:  2017-09-11       Impact factor: 5.285

Review 5.  The Current State and Validity of Digital Assessment Tools for Psychiatry: Systematic Review.

Authors:  Nayra A Martin-Key; Benedetta Spadaro; Erin Funnell; Eleanor Jane Barker; Thea Sofie Schei; Jakub Tomasik; Sabine Bahn
Journal:  JMIR Ment Health       Date:  2022-03-30

6.  Web-Based Cognitive Behavioral Therapy for Female Patients With Eating Disorders: Randomized Controlled Trial.

Authors:  Elke D ter Huurne; Hein A de Haan; Marloes G Postel; Job van der Palen; Joanne E L VanDerNagel; Cornelis A J DeJong
Journal:  J Med Internet Res       Date:  2015-06-18       Impact factor: 5.428

7.  Diagnostic validity of the MINI-KID disorder classifications in specialized child and adolescent psychiatric outpatient clinics in Sweden.

Authors:  Camilla Högberg; Eva Billstedt; Caroline Björck; Per-Olof Björck; Stephan Ehlers; Lars-Henry Gustle; Clara Hellner; Henrik Höök; Eva Serlachius; Mats A Svensson; Jan-Olov Larsson
Journal:  BMC Psychiatry       Date:  2019-05-09       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.